137 related articles for article (PubMed ID: 24956858)
1. [Research on HBV DNA inhibition of plasmid acute infection mouse with betulinic acid].
Qiao B; Gao YQ; Li M; Wu SF; Zheng C; Jin SG; Wu HC; Yu Z; Sun XH
Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(6):1097-100. PubMed ID: 24956858
[TBL] [Abstract][Full Text] [Related]
2. [Effects of amantadine and biphenyl dimethyl dicarboxylate on hepatitis B virus in hepatitis B virus replication mice].
Liu F; Jiang Z; Zhou Q; Yu Y; Meng H; Shi Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Apr; 31(2):400-4. PubMed ID: 25039150
[TBL] [Abstract][Full Text] [Related]
3. Establishment and primary application of a mouse model with hepatitis B virus replication.
Liu FJ; Liu L; He F; Wang S; Zhou TY; Liu C; Deng LY; Tang H
World J Gastroenterol; 2007 Oct; 13(40):5324-30. PubMed ID: 17879401
[TBL] [Abstract][Full Text] [Related]
4. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
[TBL] [Abstract][Full Text] [Related]
5. CpG oligodeoxynucleotide inhibits HBV replication in a hydrodynamic injection murine model.
Hu W; Huang H; Zhang TY; Mao YY; Wang XJ; Wang SQ
Antivir Ther; 2015; 20(3):289-95. PubMed ID: 25279542
[TBL] [Abstract][Full Text] [Related]
6. Construction and expression of eukaryotic plasmids containing lamivudine-resistant or wild-type strains of Hepatitis B Virus genotype C.
Xu WZ; Fang Y; Li D; Wang Y; Shang QL; Li GQ; Teng X; Gu HX
World J Gastroenterol; 2008 Jun; 14(23):3733-8. PubMed ID: 18595141
[TBL] [Abstract][Full Text] [Related]
7. Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells.
Li GQ; Xu WZ; Wang JX; Deng WW; Li D; Gu HX
World J Gastroenterol; 2007 Apr; 13(16):2324-7. PubMed ID: 17511031
[TBL] [Abstract][Full Text] [Related]
8. The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model.
Li L; Li S; Zhou Y; Yang L; Zhou D; Yang Y; Lu M; Yang D; Song J
Virol J; 2017 Oct; 14(1):205. PubMed ID: 29070073
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates.
Zhou YB; Wang YF; Zhang Y; Zheng LY; Yang XA; Wang N; Jiang JH; Ma F; Yin DT; Sun CY; Wang QD
Eur J Pharmacol; 2012 May; 683(1-3):10-5. PubMed ID: 22387093
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of anti-hepatitis B virus (HBV) drugs using the HBV transgenic mouse: application of the semiquantitative polymerase chain reaction (PCR) for serum HBV DNA to monitor the drug efficacy.
Kajino K; Kamiya N; Yuasa S; Takahara T; Sakurai J; Yamamura Ki; Hino O
Biochem Biophys Res Commun; 1997 Dec; 241(1):43-8. PubMed ID: 9405231
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
[TBL] [Abstract][Full Text] [Related]
12. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
[TBL] [Abstract][Full Text] [Related]
13. [Antiviral effect of hepatitis B virus S gene-specific anti-gene locked nucleic acid in transgenic mice].
Xiao SR; Xu GD; Wei WJ; Peng B; Deng YB
Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):17-22. PubMed ID: 29804357
[No Abstract] [Full Text] [Related]
14. Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro.
He YW; Guo CX; Pan YF; Peng C; Weng ZH
World J Gastroenterol; 2008 Mar; 14(10):1592-7. PubMed ID: 18330954
[TBL] [Abstract][Full Text] [Related]
15. [Effect of echinacoside on replication and antigen expression of hepatitis B virus].
Dai LH; Shen YM; Wu YH; Yu XP; Hu HJ; Mi YJ; Chen JJ
Zhongguo Zhong Yao Za Zhi; 2015 Aug; 40(15):3047-52. PubMed ID: 26677709
[TBL] [Abstract][Full Text] [Related]
16. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
Hu K; Huang Y; Mu J; Cheng Z; Zhu X
Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
[TBL] [Abstract][Full Text] [Related]
19. Antiviral effects of a niobium-substituted heteropolytungstate on hepatitis B virus-transgenic mice.
Li Q; Zhang H; Qi Y; Wang J; Li J; Niu J
Drug Dev Res; 2019 Dec; 80(8):1062-1070. PubMed ID: 31396981
[TBL] [Abstract][Full Text] [Related]
20. Anti-hepatitis B virus activities of α-DDB-FNC, a novel nucleoside-biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice.
Yang Q; Zhao X; Zang L; Fang X; Zhao J; Yang X; Wang Q; Zheng L; Chang J
Antiviral Res; 2012 Dec; 96(3):333-9. PubMed ID: 23098744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
